Clinical Trials Logo
  1. Home
  2. Albuminuria
  3. NCT00095290

Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria

Albuminuria Clinical Trial

Official title:
Irbesartan Versus Placebo in Combination With Standard Cardiovascular Protection ACE-I Therapy With Ramipril for the Treatment of Albuminuria in Hypertensive Subjects at Elevated Cardiovascular Risk

Clinical Trial Summary

Albumin in the urine is usually a signal that you might be at risk of cardiovascular complications. The purpose of this study is to determine if the albumin in your urine can be decreased by the treatment regimen that consists of irbesartan taken at the same time with ramipril.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00095290
Study type Interventional
Source Bristol-Myers Squibb
Contact
Status Completed
Phase Phase 4
Start date September 2004
Completion date November 2005
View Details
See also
  Status Clinical Trial Phase
Completed NCT02144740 - Effect of NWT-03 on Blood Pressure N/A
Completed NCT01041599 - Correlation of Albuminuria With Arterial Stiffness N/A
Active, not recruiting NCT05321095 - Screening for Albuminuria at the First Line for Early Identification of CKD
Completed NCT02945969 - Sodium Lowering and Urinary Protein Reduction Trial Phase 3
Enrolling by invitation NCT04295889 - Towards HOMe-based Albuminuria Screening: an Implementation Study Testing Two Approaches N/A
Recruiting NCT04272359 - Substitution of Sulfonylureas With New Generation of Hypoglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus
Completed NCT03889236 - Dietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy. N/A
Active, not recruiting NCT00625820 - Tetrahydrobiopterin in Patients With Chronic Kidney Disease (CKD) and Albuminuria Phase 2
Recruiting NCT04752293 - Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
Completed NCT03118739 - Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With Albuminuria Phase 2
Completed NCT06374043 - Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin. Phase 4
Completed NCT03396328 - Effects of Intensive Low-Salt Diet Education by Mobile Application on Albuminuria N/A
Not yet recruiting NCT06094920 - Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial Phase 4
Recruiting NCT00342927 - Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
Completed NCT02689778 - Effect of Pirfenidone on Glomerular Filtration Rate and Albuminuria in Patients With Diabetic Nephropathy Phase 3
Completed NCT02497300 - Vascular Effects of Mineralocorticoid Receptor Antagonism in Kidney Disease Phase 2
Completed NCT02446548 - Influence of Aliskiren on Albuminuria After Kidney Transplantation N/A
Completed NCT01547897 - NOX-E36 in Patients With Type 2 Diabetes Mellitus and Albuminuria Phase 2
Enrolling by invitation NCT01316068 - Effect of Sulodexide on Albuminuria in Chinese Type 2 Diabetic Patients Phase 4
Completed NCT00312780 - Study of XL784 in Patients With Albuminuria Due to Diabetic Nephropathy Phase 2